Breakthrough Biotech Holding Aps: Financial statements 2022
CVR: 42938084
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Breakthrough Biotech Holding Aps (CVR 42938084) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 0 and a net result of DKK 0. Equity in the 2022 report amounted to DKK 40,000. The solvency ratio was 100%.
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 0
- Equity
- DKK 40,000
- Total Assets
- DKK 40,000
- Employees
- 0
Official annual report
Keep an eye on Breakthrough Biotech Holding Aps
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of January 1, 2022, Jesper Smith Pedersen is registered as adm. dir. of Breakthrough Biotech Holding Aps.
About Breakthrough Biotech Holding Aps
Breakthrough Biotech Holding Aps was a Danish company of the type Anpartsselskab based in Aarhus C, founded in 2021. The company has been dissolved on 27 May 2025. The company was registered under the industry Ikke-finansielle holdingselskaber. According to the 2022 annual report, the company had an average of 0 employees. In 2023, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2023 report amounted to DKK 40,000.